caremark glp 1 CVS has announced a formulary change affecting obesity treatment. Effective July 1, Wegovy will replace Zepbound as the preferred GLP-1 medication for patients with certain plans using CVS Caremark as their Well, this is infuriating. 📬,

Learn who qualifies, what cases are pending and how to get a free case review.

But sooner or later, almost everyone on one asks the same question

We will continue to monitor the phenomenal up-take of GLP-1 drugs (recognizing its growing pipeline shown in the chart above) and patients perspectives of the use of these medications both those people prescribed them to treat medical obesity and those consumers willing to pay for them out-of-pocket

We break it down for you here.

However, there is growi...

We've helped millions check their insurance and we can leverage these insights to increase access and reduce cost for patients.